It has been reported that in situ oxygen generation via nanoparticles could relieve hypoxia and downregulate HIF-1 and c-Myc of both tumor cells and regulatory T cells, slowing down tumor progression [128, 129]. The gene discussed is MYC; the disease is neoplasm.